Treating Cytokine Storm In Patients With COVID-19

Abstract

Early recognition of COVID-19-induced cytokine storm syndrome has prognostic and therapeutic implications.[2] Although elevated cytokine levels occur in such patients, the severity of the condition might not correlate with serum cytokine concentrations due to their short half-life and diurnal variation.[3] The plasma neutrophil-to-lymphocyte ratio is an accepted intensity marker of systemic inflammation and is predictive of disease severity [4, 5] and mortality.[6]